drug · small molecule
patient view →ponatinib hydrochloride
Marketedupdated 2mo agoby $TAK TAKEDA PHARMACEUTICAL CO LTD🔗 ChEMBL
Approvedcommunity read0 votes
Small molecule drug with a maximum clinical stage of Approval (across all indications), with an approval for acute lymphoblastic leukemia and chronic myelogenous leukemia and 4 investigational indications.
targets
Bcr/Abl fusion protein
all catalysts(0)
nothing on the calendar yet
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that